PATENT CLAIM ANALYSIS

Application Number: 15913481
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "317000"]

Abstract:
The invention relates to the treatment of an attention deficit hyperactivity disorder (ADHD) with alpha-phenyl(piperidin-2-yl)methanol, or the pharmaceutically acceptable salts and esters thereof, in particular the acetate derivative, more particularly dextrophacetoperane. The invention additionally provides a method of synthesis of the (S,S) enantiomer of alpha-phenyl(piperidin-2-yl)methanol as well as a method of synthesis of dextrophacetoperane.

Claim (Index 22):
The method of  claim 19 , wherein the amount of levophacetoperane, or a pharmaceutically acceptable salt thereof, administered ranges from about 10 mg to about 20 mg.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.65909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11219416', '10199634', '15102871', '14716777', '14704836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7049663956361658
- 35 USC 102 Novelty (BERT): 0.4617192300576077
- Combined Prediction Score: 0.6806416790783101
- Mean Citation Score: 133.29998799999998
- Max Citation Score: 141.89706
- Similarity Product: 110.638276808846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test